Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

SBAR II: Application of SBAR01:14

SBAR II: Application of SBAR

4.6K
SBAR is an effective communication tool used by healthcare professionals to communicate patient information accurately. SBAR stands for Situation, Background, Assessment, and Recommendation. For a better understanding, an example is given below.
SBAR Report from a Nurse to a Health Care Provider
S: "Hello, Dr. Smith. This is Jane, RN, from the Med Surg unit. I am calling to tell you about Ms. White in Room 210, who is experiencing increased pain and redness at her incision site. Her recent...
4.6K
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

328
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
328
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

2.9K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.9K
Oral Hypoglycemic Agents: Biguanides and Glitazones01:26

Oral Hypoglycemic Agents: Biguanides and Glitazones

259
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
259
Glucagon-like Receptor Agonists01:24

Glucagon-like Receptor Agonists

383
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
383
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

226
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
226

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Implementing an Asthma Patient Decision Aid in Primary Care: A Qualitative Study of Clinicians' and Patients' Perspectives on Its Sustainability.

Journal of primary care & community health·2026
Same author

Structured patient and public involvement programme development in low- and middle-income country health research: a scoping review of evidence gaps and a framework for future practice.

Research involvement and engagement·2026
Same author

The Effect of Aligning Childhood Influenza Vaccination with Specific Well-Visits in a Primary Care Institution in Singapore.

Vaccines·2026
Same author

Healthcare utilisation patterns for paediatric functional somatic symptom presentation: a 3-year retrospective analysis.

BMC health services research·2026
Same author

Correction: Wang et al. Casein Kinase 1α as a Novel Factor Affects Thyrotropin Synthesis via PKC/ERK/CREB Signaling. <i>Int. J. Mol. Sci.</i> 2023, <i>24</i>, 7034.

International journal of molecular sciences·2026
Same author

Associations of antihypertensive, antidiabetic, and antihyperlipidemic medications with cognitive performance in an Asian population.

GeroScience·2026

Related Experiment Video

Updated: Aug 19, 2025

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

18.9K

Diabetes medication recommendation system using patient similarity analytics.

Wei Ying Tan1,2, Qiao Gao3, Ronald Wihal Oei3

  • 1Institute of Data Science, National University of Singapore, 3 Research Link, #04-06, Singapore, 117602, Singapore. idstwy@nus.edu.sg.

Scientific Reports
|December 3, 2022
PubMed
Summary

This study developed a diabetes medication recommendation system (DMRS) using patient similarity analytics to personalize treatment for type-2 diabetes mellitus (T2DM). The DMRS accurately predicts medication responses, aiding clinicians in selecting optimal therapies for T2DM patients.

More Related Videos

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

4.4K
Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.6K

Related Experiment Videos

Last Updated: Aug 19, 2025

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

18.9K
Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

4.4K
Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.6K

Area of Science:

  • Medical Informatics
  • Pharmacogenomics
  • Computational Medicine

Background:

  • Individual responses to type-2 diabetes mellitus (T2DM) pharmacotherapy vary due to clinical profiles, comorbidities, and lifestyle.
  • Personalized medicine approaches are needed to optimize T2DM treatment selection.

Purpose of the Study:

  • To develop and evaluate an evidence-based diabetes medication recommendation system (DMRS) using patient similarity analytics.
  • To predict likely patient responses to prescribed diabetes medications based on similar patient profiles.

Main Methods:

  • Utilized 10-year electronic health records (EHR) of 54,933 adult T2DM patients from Singapore.
  • Employed multiple clinical variables including demographics, comorbidities (hyperlipidaemia, hypertension), lab results, and HbA1c trajectory patterns for patient similarity analysis.
  • Evaluated DMRS recommendations using hit ratio, recall, precision, and mean reciprocal ranking against actual EHR prescriptions.

Main Results:

  • The DMRS achieved high hit ratios: 81% (no comorbidity), 84% (hyperlipidaemia), 78% (hypertension), and 75% (both comorbidities).
  • The system demonstrated the ability to provide individualized medication recommendations closely matching prescribed types and dosages.
  • Patient similarity analytics, incorporating clinical profiles and HbA1c trajectories, proved effective in predicting medication responses.

Conclusions:

  • The DMRS offers an individualized approach to T2DM pharmacotherapy selection by leveraging patient similarity.
  • The system can serve as a valuable shared decision-making tool for clinicians, enhancing the selection of appropriate diabetes medications.
  • This evidence-based system supports personalized treatment strategies for type-2 diabetes mellitus management.